skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

50 Total results for product and free and sample content found

Pharmaprojects: 医薬品開発パイプラインのデータベース


Recently, Pharma Intelligence brought you the Pharma R&D Annual Review 2020 Webinar, followed up with the NAS (New Active Substances) Infographic. We now invite you to go even deeper into pharma R&D successes for 2019 with your free copy of the NAS Supplement. 

Topic clinical-trials research

Pharmaprojects: 医薬品開発パイプラインのデータベース

New Active Substances (NAS) Launched During 2019 Infographic


Don’t miss your view into the NAS that made an impact last year, your follow-up to the Pharma R&D Annual Review 2020 webinar.

Topic Clinical Trials Research & Development

Pharmaprojects: 医薬品開発パイプラインのデータベース



世界の医薬品産業における研究開発トレンドを検証する年次ホワイトペーパー『Pharma R&D Annual Review 2020』が発行されました。1980年以来、弊社が追跡してきた世界の医薬品情報の蓄積を駆使して、会社別、治療領域別、疾病別、標的および剤型別にパイプラインを検証し、業界トレンドを評価しました。

Topic drug-development-landscape drug-review research

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Sanofi/Regeneron Refocus Kevzara COVID-19 Trial On Critical Patients, Showing Value Of A Proper Trial

A Phase III trial testing Kevzara in hospitalized COVID-19 patients will continue only with the high dose in more advanced critical patients after the low-dose was unsuccessful.

Topic Coronavirus clinical-trials research

Pharmaprojects: 医薬品開発パイプラインのデータベース



新たな10年の幕開けとともに、医薬品産業のR&Dはどこへ向かおうとしているのでしょうか。世界の製薬業界における研究開発トレンドを検証する無料ホワイトペーパー『Pharma R&D Annual Review 2020(全40頁)』が発行されました。それに合わせて、ポイントを視覚的に分かりやすく表現したインフォグラフィックも作成しました。

Topic Drug Development Landscape Drug Review Research

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus: Can Companies Achieve Vaccine Ambition?

As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.

Topic Coronovirus research vaccines

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

A Tale Of Two Pipelines

Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.

Topic Cancer Research

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Sharfstein: US FDA Incentives Not Broke, But Fix Them

The former US FDA principal deputy commissioner argues that accelerated approval, fast track and breakthrough designation standards may need updating, along with orphan and pediatric exclusivity requirements, to enhance the programs' efficacy.





電話:+81 (0)3 6273 4260